50
Participants
Start Date
June 5, 2023
Primary Completion Date
January 15, 2024
Study Completion Date
December 31, 2025
Vitamin B12 2.6 µg
There are four groups of women (n = 20 total) who will receive B12 dosing once daily, including group 1a (sufficient baseline B12, pregnant), group 1b (sufficient baseline B12, non-pregnant), group 1c (insufficient baseline B12, pregnant), and group 1d (insufficient baseline B12, non-pregnant).
Vitamin B12 10 µg
There are two groups of women (n = 10 total) who will receive B12 dosing once daily, including group 2a (sufficient baseline B12, pregnant) and group 2b (insufficient baseline B12, pregnant).
Vitamin B12 50 µg
The participants (n = 20 total) will be randomly assigned to receive either a once per day B12 dose or a twice per day B12 dose. The four groups at this dose level include: group 3a (sufficient baseline B12, pregnant, Q12), group 3b (sufficient baseline B12, Q24), group 3c (insufficient baseline B12, pregnant, Q12), group 3d (insufficient baseline B12, Q24).
Ifakara Health Institute Bagamoyo Clinical Trial Unit (BCTU), Bagamoyo
Ifakara Health Institute
OTHER
George Washington University
OTHER